A pooled multicountry analysis shows that immunisation with nirsevimab effectively reduced RSV-related hospitalisation in ...
New study shows RSV infection in early infancy can raise asthma risk later, especially in children with allergic family ...
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling ...
News-Medical.Net on MSN
Early-infancy infection with RSV increases the risk of developing childhood asthma
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling ...
The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.
Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and ...
The preventive effects of nirsevimab against respiratory syncytial virus infection persisted for up to 12 months after ...
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling evidence that early-infancy ...
“It is a one-time injection of RSV antibodies. The antibodies last for about six months, so they protect babies through that ...
News-Medical.Net on MSN
Year-round access to RSV immunization may reduce major seasonal outbreaks
Providing year-round access to RSV immunization would minimize the risk of large seasonal outbreaks across the nation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback